Description
Pharmaceutical Name: LETROZOLE 2.5®
Chemical name: 4,4′-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile
Gmed Pharma LETROZOLE 2.5® is indicated in treatment of breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy or as initial treatment of hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer.
Reviews
There are no reviews yet.